Ladenburg Thalmann Starts NextCure Inc. (nxtc) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts nxtc Hot Sheet
Price: $5.85 --0%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Join SI Premium – FREE
Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on NextCure Inc. (NASDAQ: nxtc) with a Neutral rating.
For an analyst ratings summary and ratings history on NextCure Inc. click here. For more ratings news on NextCure Inc. click here.
Shares of NextCure Inc. closed at $0.44 yesterday.
You May Also Be Interested In
- Citi initiates ATI Inc. coverage with Buy rating, $229 target
- CLSA Starts Busy Ming Group (1768:HK) at Outperform (2)
- Jones Trading Assumes Beam Therapeutics Inc (BEAM) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
